HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jennifer A Wargo Selected Research

Mouth Neoplasms (Oral Cancer)

1/2022Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jennifer A Wargo Research Topics

Disease

145Neoplasms (Cancer)
02/2024 - 03/2009
125Melanoma (Melanoma, Malignant)
04/2024 - 09/2004
15Neoplasm Metastasis (Metastasis)
01/2022 - 12/2013
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 08/2014
6Disease Progression
01/2021 - 04/2014
5Sarcoma (Soft Tissue Sarcoma)
02/2024 - 01/2018
5Infections
01/2023 - 01/2016
5Testicular Neoplasms (Testicular Cancer)
08/2014 - 05/2008
4Squamous Cell Carcinoma of Head and Neck
04/2022 - 01/2019
3Skin Neoplasms (Skin Cancer)
11/2023 - 11/2014
3Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 09/2012
3Adenocarcinoma
01/2023 - 01/2017
3Merkel Cell Carcinoma
03/2022 - 11/2016
3Pathologic Complete Response
10/2021 - 01/2019
3Tertiary Lymphoid Structures
01/2020 - 01/2020
3Renal Cell Carcinoma (Grawitz Tumor)
09/2018 - 08/2014
2Liposarcoma
02/2024 - 09/2018
2Inflammation (Inflammations)
11/2023 - 01/2023
2Colorectal Neoplasms (Colorectal Cancer)
11/2023 - 03/2012
2Obesity
11/2023 - 01/2018
2Overweight
01/2023 - 01/2018
2Fever (Fevers)
11/2022 - 01/2018
2Lung Neoplasms (Lung Cancer)
01/2022 - 10/2016
2Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 03/2016
2Experimental Melanoma
11/2020 - 06/2005
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2016
2Colitis
01/2019 - 12/2018
2Breast Neoplasms (Breast Cancer)
01/2019 - 12/2014
2Colonic Neoplasms (Colon Cancer)
01/2017 - 07/2015
2Uveal melanoma
01/2017 - 01/2016
2Urinary Bladder Neoplasms (Bladder Cancer)
11/2016 - 08/2014
2Hypoxia (Hypoxemia)
10/2016 - 12/2013
1COVID-19
04/2024

Drug/Important Bio-Agent (IBA)

53Immune Checkpoint InhibitorsIBA
02/2024 - 03/2013
26Biomarkers (Surrogate Marker)IBA
04/2024 - 07/2013
23Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023 - 12/2010
12IpilimumabIBA
02/2024 - 08/2014
12AntigensIBA
01/2022 - 06/2005
11NivolumabIBA
04/2024 - 01/2018
11VemurafenibIBA
01/2018 - 03/2012
10T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 03/2009
9RNA (Ribonucleic Acid)IBA
08/2023 - 01/2014
9Proteins (Proteins, Gene)FDA Link
01/2023 - 06/2010
8Phosphotransferases (Kinase)IBA
01/2021 - 07/2010
6Messenger RNA (mRNA)IBA
01/2022 - 01/2014
6dabrafenibIBA
01/2021 - 03/2013
6trametinibIBA
01/2021 - 03/2013
6Mitogen-Activated Protein KinasesIBA
01/2017 - 07/2010
5Anti-Bacterial Agents (Antibiotics)IBA
04/2024 - 01/2017
5Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 03/2009
5LigandsIBA
05/2019 - 10/2012
5CytokinesIBA
11/2016 - 06/2010
4Peptides (Polypeptides)IBA
01/2021 - 09/2004
4pembrolizumabIBA
01/2020 - 10/2016
4PLX 4720IBA
08/2017 - 01/2013
3DNA (Deoxyribonucleic Acid)IBA
08/2023 - 01/2022
3Interleukin-2 (IL2)IBA
01/2022 - 01/2015
3Chimeric Antigen ReceptorsIBA
01/2022 - 11/2016
3atezolizumabIBA
12/2021 - 07/2014
3Transcription Factors (Transcription Factor)IBA
01/2019 - 10/2014
3DecitabineFDA Link
08/2014 - 03/2009
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
12/2013 - 12/2010
2relatlimabIBA
03/2023 - 11/2022
2ChemokinesIBA
01/2023 - 12/2021
2Therapeutic UsesIBA
04/2022 - 03/2009
2B7-H1 AntigenIBA
01/2022 - 10/2021
2MicroRNAs (MicroRNA)IBA
01/2022 - 10/2021
2Carbapenems (Carbapenem Antibiotics)IBA
01/2022 - 01/2020
216S Ribosomal RNAIBA
01/2022 - 01/2021
2AntibodiesIBA
12/2021 - 09/2019
2aldesleukin (Proleukin)FDA Link
01/2018 - 01/2015
2HLA-A Antigens (HLA-A)IBA
01/2018 - 05/2008
2cediranib (AZD2171)IBA
08/2017 - 01/2015
2Immunomodulating AgentsIBA
02/2017 - 11/2016
2Microphthalmia-Associated Transcription FactorIBA
04/2016 - 10/2014
2Oncogene Proteins (Oncogene Protein)IBA
12/2014 - 11/2012
2Mechanistic Target of Rapamycin Complex 1IBA
12/2014 - 07/2013
2Interferon-gamma (Interferon, gamma)IBA
08/2014 - 03/2009
2MitogensIBA
07/2013 - 03/2013
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
03/2013 - 07/2010
2HLA-A*02:01 antigenIBA
01/2011 - 09/2004
1VancomycinFDA LinkGeneric
04/2024
1AndrogensIBA
02/2024
1FucosyltransferasesIBA
02/2024
1Gonadal Steroid Hormones (Sex Hormones)IBA
02/2024
1PrebioticsIBA
11/2023
1Lactic Acid (Lactate)FDA LinkGeneric
11/2023

Therapy/Procedure

106Therapeutics
08/2023 - 03/2009
71Immunotherapy
11/2023 - 09/2004
15Neoadjuvant Therapy
02/2024 - 07/2018
10Drug Therapy (Chemotherapy)
11/2023 - 08/2015
7Precision Medicine
01/2023 - 09/2015
7Fecal Microbiota Transplantation
01/2023 - 12/2018
5Radiotherapy
02/2024 - 08/2015
3Lymph Node Excision (Lymph Node Dissection)
03/2022 - 06/2009
2Withholding Treatment
01/2023 - 01/2017
2Transplantation
01/2023 - 04/2022
2Induction Chemotherapy
01/2020 - 01/2016
2Investigational Therapies (Experimental Therapy)
09/2012 - 03/2009
2Metastasectomy
12/2010 - 06/2009